Noriko Koizumi

Director/Board Member at SEED CO.,LTD.

54 year

Consumer Services

Health Technology

Technology Services

Profile

Noriko Koizumi is an Independent Outside Director at Seed Co., Ltd., a Professor at Doshisha University, the Chief Scientific Officer at ActualEyes, Inc., and a Professor at Graduate School of Medicine Kyoto University.
She received her undergraduate and doctorate degrees from Kyoto Prefectural University of Medicine.

Noriko Koizumi active positions

Companies	Position	Start
SEED CO.,LTD.	Director/Board Member	23/06/2022
Doshisha University	Corporate Officer/Principal	31/03/2010
Graduate School of Medicine Kyoto University	Corporate Officer/Principal	31/03/2015
ActualEyes, Inc. ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka.	Chief Tech/Sci/R&D Officer	30/04/2018

All active positions of Noriko Koizumi

Training of Noriko Koizumi

Kyoto Prefectural University of Medicine

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Noriko Koizumi's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SEED CO.,LTD.	Health Technology

Private companies	1
ActualEyes, Inc. ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka.	Technology Services